Fractional Sodium Excretion
Showing 1 - 25 of 5,325
Evaluation of Salt Status in Patients With Cystic Fibrosis
Completed
- Salt; Deficit (or Low)
- Cystic Fibrosis
- fractional sodium excretion
- risk subgroups
-
Gent, BelgiumGent University Hospital
Nov 30, 2022
Method of 24-hour Urinary Sodium Excretion by Using Spot Urine
Completed
- Urinary Sodium Excretion
- Salt Intakes
- No intervention
-
Beijing, ChinaBeijing Children's Hospital
Feb 28, 2022
Fractional Excretion of Urea for Differential Diagnosis of Acute
Recruiting
- Acute Kidney Injury
-
Aswan, EgyptAswan University Hospitals
Sep 25, 2021
Postural Orthostatic Tachycardia Syndrome Trial in Nashville (Plasma Volume, Exercise Capacity Test - Bicycle, Posture Study)
Completed
- Postural Orthostatic Tachycardia Syndrome
- Plasma Volume
- +2 more
-
Nashville, TennesseeVanderbilt University Medical Center
Dec 27, 2021
Blood Pressure, Psychological Stress Trial in New York (Psychological Stress Intervention)
Recruiting
- Blood Pressure
- Psychological Stress
- Psychological Stress Intervention
-
New York, New YorkColumbia University Medical Center - Shimbo Hypertension Lab
Jan 12, 2022
Postural Tachycardia Syndrome, Orthostatic Intolerance Trial in Nashville (Carbidopa, Placebo)
Completed
- Postural Tachycardia Syndrome
- Orthostatic Intolerance
- Carbidopa
- Placebo
-
Nashville, TennesseeVanderbilt University Medical Center
Jan 14, 2022
Hypertension, Overweight or Obesity, Diabetes, Type 2 Trial in Tijuana (Education group)
Recruiting
- Hypertension
- +2 more
- Education group
-
Tijuana, Baja California, MexicoNaysin Yaheko Pardo Buitimea
May 16, 2021
Healthy Trial (High dietary salt)
Not yet recruiting
- Healthy
- High dietary salt
- (no location specified)
Sep 9, 2022
Fractional Excretion of Urea for Differential Diagnosis of Acute
Not yet recruiting
- Liver Cirrhosis
- FEUrea
- (no location specified)
Feb 22, 2021
Healthy Subjects Trial in Lausanne (ACT-132577, Placebo)
Completed
- Healthy Subjects
- Aprocitentan
- Placebo
-
Lausanne, SwitzerlandInvestigator Site Lausanne
Nov 22, 2022
Infections Trial in Changchun (The injectable TQD3606, meropenem, Avibactam Sodium)
Not yet recruiting
- Infections
- The injectable TQD3606
- +3 more
-
Changchun, Jilin, ChinaAffiliated Hospital of Changchun University of Traditional Chine
Apr 20, 2022
Heart Failure With Preserved Ejection Fraction Trial in Salt Lake City (0.9% Sodium Chloride, Furosemide 40 mg)
Completed
- Heart Failure With Preserved Ejection Fraction
- 0.9% Sodium Chloride
- Furosemide 40 mg
-
Salt Lake City, UtahUniversity of Utah
Apr 14, 2021
Kidney Transplant Recipients Trial in Toronto (Dapagliflozin 10 MG, Semaglutide, 1.0 mg/mL)
Not yet recruiting
- Kidney Transplant Recipients
- Dapagliflozin 10 MG
- Semaglutide, 1.0 mg/mL
-
Toronto, Ontario, CanadaToronto General Hospital
Jul 6, 2023
Hypertension Trial in São José do Rio Preto (Evaluate if the individuals are resistant hypertensive patients)
Unknown status
- Hypertension
- Evaluate if the individuals are resistant hypertensive patients
-
São José do Rio Preto, São Paulo, BrazilFundação Faculdade Regional de Medicina (FUNFARME)
Feb 8, 2021
Heart Failure Trial in New Haven (Bumetanide Injection)
Recruiting
- Heart Failure
- Bumetanide Injection
-
New Haven, ConnecticutYale University
Sep 22, 2022
Heart Failure Trial in New Haven (Increased Intravenous Bolus Loop Diuretic Dose (Bumetanide or Furosemide), IV Chlorothiazide)
Active, not recruiting
- Heart Failure
- Increased Intravenous Bolus Loop Diuretic Dose (Bumetanide or Furosemide)
- IV Chlorothiazide
-
New Haven, ConnecticutYale University
Jul 21, 2022
Peritoneal Dialysis Complication, End Stage Kidney Disease, Sodium-glucose Co-transporter-2 Inhibitors Trial in Toronto
Not yet recruiting
- Peritoneal Dialysis Complication
- +4 more
- Empagliflozin 25 MG
-
Toronto, Ontario, CanadaToronto General Hospital
Jan 27, 2023
Diabetes, Type 2, Chronic Kidney Diseases Trial (Empagliflozin 10 MG, Placebo oral tablet, Caffeine)
Withdrawn
- Diabetes Mellitus, Type 2
- Chronic Kidney Diseases
- Empagliflozin 10 MG
- +2 more
- (no location specified)
Oct 5, 2021
Bariatric Surgery Candidate, Kidney Stone, Gastric Bypass Trial in Chicago (Special low-oxalate and low-citrate diet followed by
Recruiting
- Bariatric Surgery Candidate
- +2 more
- Special low-oxalate and low-citrate diet followed by all-day visit to University of Chicago research clinic
-
Chicago, IllinoisUniversity of Chicago Medical Center
Apr 19, 2022
Obesity, Non-diabetic Chronic Kidney Disease Trial (Empagliflozin 10 MG)
Withdrawn
- Obesity
- Non-diabetic Chronic Kidney Disease
- Empagliflozin 10 MG
- (no location specified)
Sep 6, 2021
Acute Heart Failure, Chronic Kidney Diseases Trial in Montreal (Empagliflozin 25 MG)
Not yet recruiting
- Acute Heart Failure
- Chronic Kidney Diseases
- Empagliflozin 25 MG
-
Montreal, Quebec, CanadaResearch Institute of the McGill University Health Center
Mar 29, 2022
IgA Nephropathy Trial in Xi'an (education and monitoring)
Recruiting
- IgA Nephropathy
- education and monitoring
-
Xi'an, Shaanxi, ChinaFirst affiliated hospital of Xi'an Jiaotong University
Apr 26, 2022
Salt; Excess, Hypertension Trial in Porto (SALT CONTROL H equipment to control and monitor salt during cooking process)
Active, not recruiting
- Salt; Excess
- Hypertension
- SALT CONTROL H equipment to control and monitor salt during cooking process
-
Porto, PortugalCarla Gonçalves
Jan 7, 2021
Can Help Distinguish Hypovolemic From Euvolemic Hyponatremia
Completed
- Hyponatremia
- +2 more
-
Madrid, SpainServicio de Endocrinología y Nutrición. Hospital Clínico San Car
Aug 2, 2022
Diabetes, Type 2, Kidney Function Tests Trial in Netherlands, Sweden (Dapagliflozin)
Terminated
- Diabetes Mellitus, Type 2
- Kidney Function Tests
-
Almelo, Netherlands
- +3 more
May 25, 2021